Kenvue Inc. (NYSE:KVUE) Shares Acquired by Janus Henderson Group PLC
Janus Henderson Group PLC increased its stake in Kenvue Inc. (NYSE:KVUE) by 20.2% in Q4, owning 263,969 shares valued at $5.64 million. Other institutional investors also raised their holdings. Kenvue's stock opened at $24.15, with a market cap of $46.34 billion. The company reported Q1 earnings of $0.24 per share, beating estimates, and announced a quarterly dividend of $0.205. Analysts have varied ratings, with price targets ranging from $23.50 to $29.00.
Janus Henderson Group PLC raised its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 20.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 263,969 shares of the company's stock after buying an additional 44,393 shares during the period. Janus Henderson Group PLC's holdings in Kenvue were worth $5,640,000 as of its most recent SEC filing.
- 2 Under-the-Radar Consumer Staples Stocks With Big Dividends
Several other hedge funds have also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its position in shares of Kenvue by 3.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock worth $5,249,665,000 after acquiring an additional 8,211,748 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Kenvue by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company's stock valued at $4,665,908,000 after acquiring an additional 1,636,741 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Kenvue by 12.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company's stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Geode Capital Management LLC grew its position in Kenvue by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company's stock worth $980,989,000 after purchasing an additional 1,391,854 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in Kenvue by 61.5% during the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company's stock worth $912,059,000 after purchasing an additional 16,269,721 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.
Kenvue Trading Up 1.1%
Shares of NYSE KVUE opened at $24.15 on Monday. The business has a 50 day simple moving average of $23.16 and a 200 day simple moving average of $22.59. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17. The stock has a market cap of $46.34 billion, a price-to-earnings ratio of 45.57, a PEG ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.
- Johnson & Johnson Stock: Setting the Stage for 2025 Highs
Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm had revenue of $3.74 billion during the quarter, compared to analysts' expectations of $3.69 billion. During the same period in the previous year, the company earned $0.28 earnings per share. The company's revenue was down 3.9% compared to the same quarter last year. On average, research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.
Kenvue Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date is Wednesday, May 14th. Kenvue's dividend payout ratio is presently 149.09%.
Analyst Ratings Changes
- Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
A number of brokerages have recently weighed in on KVUE. Piper Sandler lifted their price target on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a report on Monday, February 24th. Royal Bank of Canada restated a "sector perform" rating and set a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Redburn Atlantic started coverage on Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 target price on the stock. Citigroup increased their price target on shares of Kenvue from $22.00 to $24.50 and gave the stock a "neutral" rating in a research report on Friday, May 9th. Finally, Canaccord Genuity Group raised their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a report on Wednesday, March 5th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $25.33.
View Our Latest Analysis on KVUE
Kenvue Profile
(Free Report)Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Further Reading
- Five stocks we like better than Kenvue
- Investing In Preferred Stock vs. Common Stock
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Savvy Investors Are Raising a Glass for Heineken Stock
- The Risks of Owning Bonds
- Top 4 ETFs for China Exposure After Tariff Relief
Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Kenvue Right Now?
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
